Table of contents

Oral candidiasis


Key sources

The following summarized guidelines for the management of oral candidiasis are prepared by our editorial team based on guidelines from the Infectious Diseases Society of America (IDSA/CDC/NIH/HIVMA 2024), the Infectious Diseases Society of America (IDSA 2016), and the European Society for Microbiology and Infectious Diseases (ESCMID 2012). ...
Show more

Medical management

Antifungal therapy: as per IDSA 2016 guidelines, offer any of the following in patients with mild OC:
clotrimazole troches 10 mg 5 times daily for 7-14 days
miconazole mucoadhesive buccal 50 mg tablet applied to the mucosal surface over the canine fossa once daily for 7-14 days.
Show 5 more
Create free account

Specific circumstances

Pregnant patients: as per CDC/HIVMA/IDSA/NIH 2024 guidelines, do not use voriconazole, anidulafungin and caspofungin in pregnant patients.
Show 2 more

More topics in this section

  • Patients with denture-related candidiasis

  • Patients with HIV (prevention)

  • Patients with HIV (antifungal therapy)

  • Patients with HIV (management of treatment failure)

Preventative measures

Chronic suppressive therapy
As per IDSA 2016 guidelines:
Avoid offering chronic suppressive therapy in patients with OC.
Offer fluconazole 100 mg 3 times weekly if chronic suppressive therapy is required in patients with recurrent infection.